Medical Xpress·4 min read·hard
Experimental drug alleviates symptoms of Huntington's disease
J
Julius Maximilian University of Würzburg
✦AI Summary
Researchers have identified a drug candidate, anle138b, that reduces toxic protein clumps in the brains of mice with Huntington's disease. The study suggests the drug could slow disease progression and extend lifespan, with promising results also observed in human stem cells.
Why it matters
This is a significant potential breakthrough for treating a currently incurable neurodegenerative disorder.
by Julius Maximilian University of Würzburg
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
The article is a scientific report based on peer-reviewed research.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in